Tue, 09 May|
2022 ISI Annual Award for Immunology & Public Lecture
The Irish Society for Immunology are delighted to award Prof. Ed Lavelle their Annual Award for Immunology 2022. Prof. Lavelle will present a public lecture entitled “Getting to the core of how vaccines work” as part of his award ceremony.
Time & Location
09 May, 19:00
Tercentenary Hall, Trinity College Dublin, 152 - 160 Pearse St, Dublin, D02 R590, Ireland
About the Event
The Irish Society for Immunology are delighted to award Prof. Ed Lavelle their Annual Award for Immunology 2022 for his contributions to Irish immunology research and education.
Prof. Lavelle will present a public lecture entitled “Getting to the core of how vaccines work” as part of his award ceremony in Tercentenary Hall, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2. (Date TBC). This lecture will also mark part of the ISI’s contribution to the European Day of Immunology on 29th April 2023.
Biography - Prof. Ed Lavelle
Professor Ed Lavelle is the current Professor of Vaccine Immunology in Trinity College Dublin, Ireland where he leads an internationally recognised group working on vaccine research and development. He was elected a member of the Royal Irish Academy (MRIA) in 2021 in recognition of his contribution to the vaccine field. He is the current President of European Congress of Immunology (ECI) 2024 and former President of the Irish Society for Immunology (ISI). He previously held the position of Head of the School of Biochemistry and Immunology at Trinity College Dublin.
Prof. Lavelle graduated with a BSc (Hons) in Microbiology from University College Galway and a PhD in Immunology from the University of Plymouth. He carried out postdoctoral research at the University of Nottingham, Rowett Research Institute and Trinity College Dublin on vaccine adjuvants and immunomodulation. Subsequently, he was appointed at Trinity College Dublin as lecturer in 2004, an associate Professor in 2012 and a Professor in Immunology in 2015.
Prof. Lavelle’s main research area is the development of injectable and mucosal vaccines for infectious diseases and resolving their mode of action. His research group in Trinity College Dublin is also focused on developing therapeutic vaccines for cancer and investigating vaccine strategies that promote immunogenic cell death leading to enhanced protective immunity.